Soon the crunch has to come for smaller companies and they will have to produce full or abbreviated accounts each quarter to give the full picture. We have USA office being paid for by AEB's partner client , the partner paying to build it's own plant and AEB recording income on supply of goods to that plant we assume. It is just a odd way of doing business but that is what you get in the world of small cash strapped small caps who have to stay liquid or go out the back door
Small trade this morning at .071c and there is no buyers of note nor sellers. Not loved and not watched it seems .
News flow in the next quarter and after will be interesting as there has to be a deadline at some point in getting the India plant actually running and the timetable for that will be interesting. i still see this as the Indians having a cheap punt and getting access to the exact strains of algae that have supposedly worked for AEB in the lab. After that all bets are off as the monster will do what it wants and the AEB minnow will be stranded as it is very rare for the indian companies to do aussie acquisitions and they have a special manner in doing so which in others I have followed hasn't been beneficial to small aussie holders who are basically diluted out.
A update on the time line from AEB is needed and explanation of why they are not proceeding with massively profitable supplements production in Australia as they proposed? Just what are the new premises and mothballed plant down there being used for? Why didn't they just send that plant over to India as it was operational rather than build another? Scaling up risk is very great with any process but unsure if the scale up is happening by bigger vessels or in a modular manner.
Add to My Watchlist
What is My Watchlist?